-
1 Comment
Zhejiang Xianju Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.
From a valuation standpoint, the stock is 67.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Zhejiang Xianju Pharmaceutical Co.,Ltd's total revenue rose by 23.8% to $1B since the same quarter in the previous year.
Its net income has increased by 28.1% to $153M since the same quarter in the previous year.
Finally, its free cash flow grew by 113.6% to $228M since the same quarter in the previous year.
Based on the above factors, Zhejiang Xianju Pharmaceutical Co.,Ltd gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | CNE100000K64 |
| Beta | 0.22 |
|---|---|
| Market Cap | 9B |
| Target Price | 16.3575 |
| PE Ratio | 14.71 |
| Dividend Yield | 3.2% |
Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002332.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
